NewsASA Releases New Primary Stroke Prevention GuidelineAuthor:Caroline CasselsPublish date: October 21, 2024The updated guideline calls for better primary stroke prevention that includes improved screening and lifestyle changes.Read More
NewsFDA approves buprenorphine injection for opioid use disorderAuthor:Caroline CasselsPublish date: May 25, 2023Brixadi is approved in both weekly and monthly subcutaneous injectable formulations at varying doses.Read More
NewsFDA clears diagnostic test for early Alzheimer’sAuthor:Caroline CasselsPublish date: May 5, 2022“There is a new option that can typically be completed the same day and can give doctors the same information regarding brain amyloid status, witho...Read More
NewsFDA okays new drug option for schizophrenia, bipolar I disorderAuthor:Caroline CasselsPublish date: June 1, 2021The FDA approved Lybalvi under the 505(b)(2) regulatory pathway based on data from 27 clinical studies.Read More
NewsFDA approves first IV migraine prevention drugAuthor:Caroline CasselsPublish date: February 24, 2020“The PROMISE-2 data showed that many patients can achieve reduction in migraine days of at least 75% and experience a sustained migraine improvemen...Read More
